Hinge Health, Inc. (HNGE) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 5, 2025, announces the financial results for Hinge Health, Inc. for the second quarter ended June 30, 2025. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in San Francisco, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K serves as a notification that a press release (Exhibit 99.1) containing these details has been issued. The press release includes both GAAP and non-GAAP financial measures, with reconciliations provided therein.
Material Changes and Comparisons
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for year-over-year or quarter-over-quarter performance analysis.
Guidance, Outlook, and Management Commentary
- Conference Call: Management held a conference call on August 5, 2025, at 1:30 p.m. Pacific time to discuss the financial results.
- Non-GAAP Measures: The Company utilizes non-GAAP financial information in its disclosures, with reconciliations to GAAP equivalents provided in the press release.
- Regulation FD: Supplemental investor materials were posted on the Company's investor relations website (ir.hingehealth.com) on August 5, 2025.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2025 revenue, net loss, and cash position figures.
- Examine the reconciliation of non-GAAP financial measures to GAAP equivalents in the press release.
- Check the investor relations website for supplemental materials referenced under Item 7.01.
- Verify the transcript or recording of the August 5, 2025, conference call for management commentary on future guidance and risks.